Failure Mode and Effects Analysis (FMEA) for Immunogenicity of Therapeutic Proteins-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Failure Mode and Effects Analysis (FMEA) for Immunogenicity of Therapeutic Proteins

Published:2020-10 Issue:10 Volume:109 Page:3214-3222
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Chirmule Narendra,Khare Ravindra,Khandekar Atul,Jawa Vibha

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference40 articles.

1. From the bench to clinical practice: understanding the challenges and;Gunn;Clin Exp Immunol,2016

2. T-cell dependent immunogenicity of protein therapeutics: preclinical assessment;Jawa;Clin Immunol,2013

3. Assessment and reporting of the clinical immunogenicity of therapeutic proteins;Shankar;AAPS J,2014

4. Revised Guideline to Assess Risk of Human Medicines for the Environment,2018

5. Immunogenicity Testing of Therapeutic Protein Products — Developing and Validating Assays for Anti-drug Antibody Detection,2019

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Contract development and manufacturing organization selection: critical considerations that can make or break your cell and gene therapy development;Cytotherapy;2024-07

2. Using Failure Mode and Effect Analysis to Identify Potential Failures in a Psychiatric Hospital Emergency Department;Journal of Patient Safety;2023-05-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP